COMMON WARTS

Clinical trials for COMMON WARTS explained in plain language.

Never miss a new study

Get alerted when new COMMON WARTS trials appear

Sign up with your email to follow new studies for COMMON WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 1

Can a blister beetle extract banish common warts? phase 3 trial investigates

Disease control Not yet recruiting

This Phase 3 trial tests YCANTH, a topical solution containing cantharidin (a substance from blister beetles), against a placebo for treating common warts. About 300 people aged 2 and older with at least one wart on their body (excluding certain areas) will receive either the act…

Matched conditions: COMMON WARTS

Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:08 UTC

COMMON WARTS

Get alerted when new COMMON WARTS trials appear

Can a blister beetle extract banish common warts? phase 3 trial investigates